Medpace Holdings (MEDP) Liabilities and Shareholders Equity (2015 - 2026)

Medpace Holdings (MEDP) has reported Liabilities and Shareholders Equity for 12 consecutive years, with $2.1 billion the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Liabilities and Shareholders Equity rose 30.89% year-over-year to $2.1 billion; the trailing twelve-month figure through Jun 2026 stood at $7.9 billion (up 3.41% YoY), and the FY2025 full-year result was $2.0 billion, down 5.97% from the prior year.
• Liabilities and Shareholders Equity fell to $2.1 billion in Q2 2026 per MEDP's latest filing, from $2.1 billion in the prior quarter.
• Across five years, Liabilities and Shareholders Equity topped out at $2.1 billion in Q1 2026 and bottomed at $1.3 billion in Q2 2022.
• Historically, Liabilities and Shareholders Equity has averaged $1.7 billion across 5 years, with a median of $1.7 billion in 2023.
• The sharpest annual moves came in 2022 and 2024: Liabilities and Shareholders Equity retreated 18.52% in 2022, then surged 40.18% in 2024.
• Over 5 years, Liabilities and Shareholders Equity stood at $1.4 billion in 2022, then climbed by 22.5% to $1.7 billion in 2023, then climbed by 26.8% to $2.1 billion in 2024, then retreated by 5.97% to $2.0 billion in 2025, then gained by 4.14% to $2.1 billion in 2026.
• According to Business Quant data, Liabilities and Shareholders Equity over the past three periods registered $2.1 billion, $2.1 billion, and $2.0 billion for Q2 2026, Q1 2026, and Q4 2025 respectively.